Related Experiment Video
Updated: Aug 5, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Management of chronic renal insufficiency: a call for a proactive approach
1Tufts University School of Medicine, New England Medical Center, Boston, USA.
Insights
Chronic renal insufficiency (CRI) affects millions, often progressing to end-stage renal disease. Early diagnosis and treatment of anemia associated with CRI, potentially through initiatives like the Renal Anemia Management Period (RAMP), can slow disease progression and reduce complications.
Area of Science:
- Nephrology
- Internal Medicine
- Public Health
Background:
- Chronic renal insufficiency (CRI) affects approximately 6.2 million Americans.
- CRI is a progressive condition often stemming from diabetes, hypertension, and glomerulonephritis.
- End-stage renal disease necessitates dialysis or transplantation for survival.
Purpose of the Study:
- To highlight the opportunity for early intervention in CRI patients.
- To emphasize the role of primary care physicians, nephrologists, and payers in managing renal disease.
- To promote awareness of anemia as a significant comorbidity in CRI.
Main Methods:
- The abstract discusses the potential impact of the Renal Anemia Management Period (RAMP).
- It focuses on the importance of early diagnosis and aggressive treatment strategies.
- The approach involves identifying at-risk populations and implementing proactive management.
Main Results:
- Early diagnosis and treatment of anemia in CRI patients can mitigate morbidity.
- Aggressive management has the potential to slow the progression of renal disease.
- Intervention can prevent or control significant complications and mortality.
Conclusions:
- Proactive management of CRI and its associated anemia is crucial.
- Initiatives like RAMP can improve patient outcomes by increasing awareness and promoting timely treatment.
- Interdisciplinary collaboration among healthcare providers and payers is essential for effective renal disease management.
Abstract:
As many as 6.2 million Americans may have chronic renal insufficiency (CRI), an insidious disease that can arise as a result of diabetes, hypertensive nephrosclerosis, chronic glomerulonephritis, and many other disorders. CRI usually progresses over time to end-stage renal disease, when patients require either dialysis or kidney transplantation in order to survive. With this population identified, primary care physicians, nephrologists, and payers have an opportunity to prevent or at least slow the progression of renal disease. The Renal Anemia Management Period (RAMP) may help raise awareness of the need for early diagnosis and aggressive treatment of anemia, one of the leading causes of morbidity in CRI patients. Such treatment has the potential to prevent or control the development of significant morbidity and mortality.
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management

